Multiple Sclerosis Trial, Recruiting NCT05491031 Sponsor: Poitiers University Hospital Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT05491031
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have had their condition for 25 years or less
  • People whose level of permanent disability is 7 or below on a standard MS disability scale (meaning they are not permanently confined to a wheelchair)

Who may not be able to join:

  • People who have another progressive neurological disease (separate from MS)
  • People who have only incidental findings on brain scans without a confirmed MS diagnosis (known as Radiologically Isolated Syndrome)
  • People with severe, unstable psychiatric conditions
  • People who have changed their dose, stopped, or started a psychiatric medication within the last month
  • People who have changed their main MS treatment within the last 3 months
  • People who have had a course of steroid treatment (by mouth or through a drip) within the last month
  • People who cannot safely have an MRI scan — this includes those who are pregnant, or who have certain metal implants or electronic medical devices in their body, such as a pacemaker, implanted defibrillator, cochlear implants, certain neurostimulators, metallic eye fragments, metallic heart valves, vascular clips, or similar devices (confirm with trial site if unsure whether a specific implant applies)
  • People who are unable to read or write in French, or who do not speak French
  • People in certain protected legal categories, including those under 18, people whose liberty is restricted by a court or government order, people living in a health or social care facility, adults under legal guardianship, or people in an emergency medical situation
  • Women who are pregnant or breastfeeding, and women of childbearing age for whom effective contraception is not in place (hormonal, mechanical, or surgical methods are listed as acceptable — confirm with trial site for specifics)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33.5.49.44.44.46

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poitiers University Hospital
Registry
ClinicalTrials.gov
Start date
25 April 2023
Est. completion
1 May 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Identify imaging biomarkers at inclusion predictive of disability progression.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov